Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition.
about
Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserineI-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activationLinks between complement deficiency and apoptosis.Natural Antibodies as Rheostats for Susceptibility to Chronic Diseases in the AgedThe Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human DiseasesEmerging role of mast cells and macrophages in cardiovascular and metabolic diseasesUnderstanding the role of B cells in atherosclerosis: potential clinical implicationsThe influence of innate and adaptive immune responses on atherosclerosisNucleic acids and endosomal pattern recognition: how to tell friend from foe?Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity.Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunityPhenolic antioxidants trolox and caffeic acid modulate the oxidized LDL-induced EGF-receptor activationAntiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipidsSurfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung DiseaseThe innate immune response to products of phospholipid peroxidationGeneration and biological activities of oxidized phospholipidsContribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and AutoimmunityKidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cellsThe binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoproteinDo not let death do us part: 'find-me' signals in communication between dying cells and the phagocytes.Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.B cell subsets in atherosclerosis.Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase.Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression.Vaccine against arteriosclerosis: an update.Macrophage Apoptosis and Efferocytosis in the Pathogenesis of AtherosclerosisB cells and humoral immunity in atherosclerosisProgrammed cell clearance: molecular regulation of the elimination of apoptotic cell corpses and its role in the resolution of inflammation.A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.Enhanced uptake of multiple sclerosis-derived myelin by THP-1 macrophages and primary human microglia.An appetite for apoptotic cells? Controversies and challenges.Immune recognition of OxLDL in atherosclerosis.Apoptosis in the vasculature: mechanisms and functional importance.Plasminogen promotes macrophage phagocytosis in miceOxidized phosphatidylcholines: pattern recognition ligands for multiple pathways of the innate immune response.C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipidsRecognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein.IgM-antibodies against phosphorylcholine in mothers and normal or low birth weight term newborn infants.
P2860
Q23923115-9C5638D2-C421-4C25-949E-9AFEBB9AF477Q24673242-1967D102-456E-4C74-9DB4-84AB28D9D533Q24805502-12D205D8-F5C3-4ED5-BEE3-B6ED82F176BCQ26752508-9190812B-689F-4637-B113-B53FF502F1CAQ26752888-BDE8DA24-495E-4D92-B967-1EDEA73E64AEQ26825467-3F9F09D7-D883-4BCE-8868-DF3A3F64EF12Q26991813-81478315-AF16-4468-BFC2-0D4FF72C1FCEQ27000370-3A85EC66-1B7C-4D14-B166-13E03289CCB9Q27022525-6CF1FC82-F89C-4E50-B0F8-8B46810432A3Q28304843-7C006A1A-5CC7-41A0-9A65-C57C5F70B626Q28344371-B0B65CF0-7C7B-49EA-A8BA-B46A8F3ED8ACQ28363066-49270599-A376-4F9F-82E8-436D3C8DFDE3Q28364192-CA45D33A-ECAE-4832-8906-286DE646EAE6Q28383936-6850807D-9D1A-46FE-8DC7-77E4270D9D8FQ28389385-5C1C6582-598E-4666-A613-FF7A02874E65Q28389691-BE563D30-E785-4A67-BEE0-E07EA5BEDB3BQ28397407-729BBE06-0497-499B-A1A9-2B00F6AE5913Q28573345-B0DF405D-DEFB-4433-B439-E32CB3E79361Q28647592-3AB18C35-7D65-4F62-81D4-9C3B6266D41CQ30277318-A79605E2-2FE1-4B74-805D-066343FA1843Q30413616-3C4365E3-C442-4299-874B-10C430B7A104Q30423324-0ECF4530-D07E-43FE-9954-5B9AC200A03EQ30480611-5ADA8C3C-EF41-4017-AB3D-AE449F29917BQ31114066-F02F35E5-AA99-4B6C-8FE8-681E0D32FC52Q33412152-E27597F0-31F8-46C6-896D-63A3878F686FQ33586616-922D7D33-0C94-45D4-AF3B-C63270120686Q33641227-8DFDD767-EC55-4363-A463-33A0FABF8A21Q33764821-324E0B30-9A97-49A9-8B2F-4EBD5469431FQ33789638-092709C4-25D0-402E-B02E-CA346926B790Q33875438-4EE57BDD-6929-4E83-9858-95A2AEC865F5Q33912964-02599C56-4A34-490B-82E3-9EC449279002Q33939178-6CB2ED6E-B88E-46F5-A252-6B17E39CA366Q33940235-D94652C7-0EBB-47F1-87E9-282DEA68D6A9Q33947786-AD790779-F5CA-479A-97D1-3B0233D57C78Q33959479-DAA3CBDE-609C-411A-8FB6-BA1329716220Q33987072-8CC2A134-BAB8-497C-9587-6FD73C65C5BAQ34188034-EC348AA5-4C4E-4EF5-9713-49E6191E1ABDQ34191416-6969CEC5-4158-4C1D-96C4-2A3C20704CAAQ34230397-9340196E-EE2C-4490-9355-ECFC2A7D1364Q34275789-657FA173-BA03-49FF-AFCB-A00176A3C837
P2860
Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Monoclonal antibodies against ...... ediate macrophage recognition.
@en
Monoclonal antibodies against ...... ediate macrophage recognition.
@nl
type
label
Monoclonal antibodies against ...... ediate macrophage recognition.
@en
Monoclonal antibodies against ...... ediate macrophage recognition.
@nl
prefLabel
Monoclonal antibodies against ...... ediate macrophage recognition.
@en
Monoclonal antibodies against ...... ediate macrophage recognition.
@nl
P2093
P2860
P921
P356
P1476
Monoclonal antibodies against ...... ediate macrophage recognition.
@en
P2093
C Bergmark
E A Dennis
J L Witztum
P Friedman
P2860
P304
P356
10.1073/PNAS.96.11.6353
P407
P577
1999-05-01T00:00:00Z